[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

LU85721A1 - Compose antibiotique,procede pour le preparer et compositions le contenant - Google Patents

Compose antibiotique,procede pour le preparer et compositions le contenant Download PDF

Info

Publication number
LU85721A1
LU85721A1 LU85721A LU85721A LU85721A1 LU 85721 A1 LU85721 A1 LU 85721A1 LU 85721 A LU85721 A LU 85721A LU 85721 A LU85721 A LU 85721A LU 85721 A1 LU85721 A1 LU 85721A1
Authority
LU
Luxembourg
Prior art keywords
stearate
erythromycin
acetyl
erythromycin stearate
same
Prior art date
Application number
LU85721A
Other languages
English (en)
French (fr)
Inventor
Martti L A Marvola
Esko V Marttila
Jaakko A Uotila
Aino K Pippuri
Pekka J Kairisalo
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of LU85721A1 publication Critical patent/LU85721A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
LU85721A 1984-01-06 1985-01-04 Compose antibiotique,procede pour le preparer et compositions le contenant LU85721A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
DK5884 1984-01-06

Publications (1)

Publication Number Publication Date
LU85721A1 true LU85721A1 (fr) 1985-07-24

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85721A LU85721A1 (fr) 1984-01-06 1985-01-04 Compose antibiotique,procede pour le preparer et compositions le contenant

Country Status (38)

Country Link
US (1) US4599326A (da)
JP (1) JPS60158197A (da)
KR (1) KR900006237B1 (da)
AT (1) AT386414B (da)
AU (1) AU565688B2 (da)
BE (1) BE901411A (da)
BG (1) BG43189A3 (da)
CA (1) CA1224461A (da)
CH (1) CH666275A5 (da)
CS (1) CS247191B2 (da)
CY (1) CY1462A (da)
DE (1) DE3500179A1 (da)
DK (1) DK149776C (da)
ES (1) ES8605818A1 (da)
FI (1) FI77249C (da)
FR (1) FR2557878B1 (da)
GB (1) GB2152502B (da)
HK (1) HK11590A (da)
HU (1) HU196221B (da)
IE (1) IE57967B1 (da)
IL (1) IL73885A (da)
IS (1) IS2968A7 (da)
IT (1) IT1184304B (da)
KE (1) KE3841A (da)
LU (1) LU85721A1 (da)
MA (1) MA20316A1 (da)
MX (1) MX156277A (da)
NL (1) NL8403979A (da)
NO (1) NO160263C (da)
NZ (1) NZ210606A (da)
PH (1) PH22471A (da)
PL (1) PL144349B1 (da)
PT (1) PT79777B (da)
RO (1) RO91262B (da)
SE (1) SE461854B (da)
SU (1) SU1410866A3 (da)
YU (1) YU44485B (da)
ZA (1) ZA8410143B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル, インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
JP2007509976A (ja) * 2003-10-31 2007-04-19 アルザ・コーポレーシヨン 増加された鉄の吸収のための組成物及び投与形態
PT1765292T (pt) 2004-06-12 2017-12-29 Collegium Pharmaceutical Inc Formulações de fármacos dissuasoras de abuso
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
WO2007149096A1 (en) 2006-06-23 2007-12-27 Aegis Therapeutics, Inc. Stabilizing alkylglycoside compositions and methods thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CN108892709A (zh) 2011-05-18 2018-11-27 欧莫德里斯制药公司 改良的肽药物
KR102365582B1 (ko) 2012-11-20 2022-02-18 메더리스 다이어비티즈, 엘엘씨 인슐린 저항성에 대한 개선된 펩티드 약제
ES2906975T3 (es) 2012-11-20 2022-04-21 Eumederis Pharmaceuticals Inc Productos farmacéuticos de péptidos mejorados
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
NZ757113A (en) 2014-05-28 2022-08-26 Mederis Diabetes Llc Improved peptide pharmaceuticals for insulin resistance
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
RU2019142102A (ru) 2017-05-19 2021-06-21 Лунелла Байотек, Инк. Антимитосцины: направленные ингибиторы митохондриального биогенеза для эрадикации злокачественных стволовых клеток
WO2019108729A1 (en) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
MX2020008132A (es) 2018-02-06 2020-11-18 Aegis Therapeutics Llc Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades.
KR20210104830A (ko) * 2018-12-17 2021-08-25 루넬라 바이오테크 인코포레이티드 항노화를 위한 삼중 조합 요법
CN113573715A (zh) * 2018-12-17 2021-10-29 卢内拉生物技术有限公司 用于靶向线粒体和杀死癌症干细胞的三联疗法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FR2557878A1 (fr) 1985-07-12
JPH029040B2 (da) 1990-02-28
JPS60158197A (ja) 1985-08-19
IE57967B1 (en) 1993-06-02
PT79777B (en) 1986-10-21
DK5884A (da) 1985-07-07
RO91262A (ro) 1987-06-30
SE461854B (sv) 1990-04-02
BG43189A3 (en) 1988-04-15
IT1184304B (it) 1987-10-28
NL8403979A (nl) 1985-08-01
HUT37628A (en) 1986-01-23
DK149776C (da) 1987-04-21
PL251457A1 (en) 1985-11-05
CY1462A (en) 1989-07-21
DK149776B (da) 1986-09-29
NO160263C (no) 1989-03-29
NZ210606A (en) 1987-08-31
PL144349B1 (en) 1988-05-31
AU3705984A (en) 1985-07-11
NO850007L (no) 1985-07-08
IL73885A (en) 1988-10-31
AU565688B2 (en) 1987-09-24
ATA985A (de) 1988-01-15
CS247191B2 (en) 1986-12-18
GB8432368D0 (en) 1985-02-06
SE8406671L (sv) 1985-07-07
IT8519012A0 (it) 1985-01-04
MX156277A (es) 1988-08-04
HU196221B (en) 1988-10-28
HK11590A (en) 1990-02-23
PT79777A (en) 1985-01-01
FI77249B (fi) 1988-10-31
IE850022L (en) 1985-07-06
IS2968A7 (is) 1985-04-03
GB2152502B (en) 1987-10-07
KE3841A (en) 1989-04-07
ES539349A0 (es) 1986-04-01
IL73885A0 (en) 1985-03-31
DE3500179C2 (da) 1989-08-24
ZA8410143B (en) 1985-08-28
CH666275A5 (de) 1988-07-15
DE3500179A1 (de) 1985-07-18
US4599326A (en) 1986-07-08
MA20316A1 (fr) 1985-10-01
SE8406671D0 (sv) 1984-12-28
FR2557878B1 (fr) 1988-01-15
SU1410866A3 (ru) 1988-07-15
PH22471A (en) 1988-09-12
KR900006237B1 (ko) 1990-08-27
NO160263B (no) 1988-12-19
BE901411A (fr) 1985-04-16
CA1224461A (en) 1987-07-21
FI77249C (fi) 1989-02-10
DK5884D0 (da) 1984-01-06
RO91262B (ro) 1987-07-01
AT386414B (de) 1988-08-25
ES8605818A1 (es) 1986-04-01
FI850023L (fi) 1985-07-07
GB2152502A (en) 1985-08-07
YU44485B (en) 1990-08-31
FI850023A0 (fi) 1985-01-03
KR850005452A (ko) 1985-08-26
YU2085A (en) 1987-12-31

Similar Documents

Publication Publication Date Title
LU85721A1 (fr) Compose antibiotique,procede pour le preparer et compositions le contenant
CN101300230A (zh) 作为杀虫剂的n-(杂)芳基吲哚衍生物
CN103228668B (zh) 抗糖尿病的苯基丙酮酸烯醇糖苷
CH646412A5 (fr) Procede de preparation des produits hydrosolubles a base de (+)-catechine et compositions contenant ces produits.
FR2495160A1 (fr) Derive de bisglucosylmoranoline et compositions pharmaceutiques pour le traitement du diabete sucre qui le renferment
LU84428A1 (fr) Nouveaux derives de l'acide 4-phenyl 4-oxo 2-butenoique,leurs sels,leur preparation,leur application comme medicaments et les compositions les renfermant
CA1199582A (fr) Forme medicamenteuse de theophylline a action prolongee
EP0117171B1 (fr) Dérivés aminés de la pyridazine substitués en position 6 par un hétérocycle ou un alicycle, procédé d'obtention et médicaments les contenant
CN116157120A (zh) 包含苯并呋喃基n-酰腙衍生物的抗炎组合物
EP2931266B1 (fr) Composition et kit comprenant des dérivés de pipérazine et de la metformine, leur utilisation dans le traitement du diabète
WO1981002295A1 (fr) Phenoxyisobutyrates de moroxydine et medicaments les contenant
FR2801055A1 (fr) Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique
BE1001774A4 (fr) Composition pharmaceutique antivirale s'accumulant dans la peau, applicable par voie externe et procede pour sa preparation.
LU85716A1 (fr) Procede de preparation d'un nouveau compose complexe d'hemine ayant des applications medicales
EP0155872A1 (fr) Procédé de réduction du taux de lignine dans les végétaux et nouvelles compositions pour sa mise en oeuvre
JP3759207B2 (ja) 抗菌剤及び医薬組成物
BE875451A (fr) Nouveaux medicaments constitues de derives de l'acide p-amino-benzoique
CN116265463A (zh) 一种醛糖还原酶抑制剂的晶型及其制备方法和应用
BE880713A (fr) Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
CA2127545A1 (fr) Nouvelle application therapeutique de derives de pyridylpyrrolothiazole carboxamide
FR2472577A1 (fr) Nouveaux derives de l'acide aminobenzoique
EP1007522A1 (fr) 2- 4-[4-(4,5-dichloro -2-methylimidazol-1-yl) butyl]-1-piperazinyl -5-fluoropyrimidine, sa preparation et son utilisation therapeutique
BE572026A (da)
BE633874A (da)
BE564915A (da)